Latest Articles

  • Purpuric lesion on the elbow
    Naveen K. Voore, MD, Asima Rahman, MD, MRCGP, MRCOG, Sathish Sanna, MD and Huzefa Bahrain, DO
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 253-256; DOI: https://doi.org/10.3949/ccjm.79a.11036

    A 75-year-old man developed a painful lesion on the elbow several days after starting warfarin therapy. What is the most likely diagnosis?

  • In Reply: Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04005

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 236-237; DOI: https://doi.org/10.3949/ccjm.79c.04002

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Factor V Leiden: How great is the risk of venous thromboembolism?
    Khaldoon Shaheen, MD, M. Chadi Alraies, MD, FACP, Abdul Hamid Alraiyes, MD and Richard Christie, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 265-272; DOI: https://doi.org/10.3949/ccjm.79a.11072

    The risk of a first episode of thromboembolism is two to five times higher with the heterozygous factor V Leiden mutation, but the absolute risk is still low.

  • In Reply: Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    M. Cecilia Lansang, MD, MPH and Leighanne Kramer Hustak, DNP, BC-FNP, CDE
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 237-242; DOI: https://doi.org/10.3949/ccjm.79c.04003

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Examine before ordering: An algorithm unchanged by new tests
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 234; DOI: https://doi.org/10.3949/ccjm.79b.12004

    I have always been irked when doctors reflexively order panels of immunologic tests when evaluating patients with “arthritis.”

  • Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    Rene Rodríguez-Gutiérrez, MD and José Gerardo González-González, MD, PhD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 236; DOI: https://doi.org/10.3949/ccjm.79c.04001

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Should I order an anti-CCP antibody test to diagnose rheumatoid arthritis?
    Nilanjana Bose, MD and Leonard H. Calabrese, DO
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 249-252; DOI: https://doi.org/10.3949/ccjm.79a.11008

    This test is highly specific, though it may be redundant for a patient who has documented rheumatoid arthritis and who is seropositive for rheumatoid factor.

  • Parkinson disease (January 2012)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242-243; DOI: https://doi.org/10.3949/ccjm.79c:04006

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04004

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

Pages